Get the Stockscreener App
1.57
0.64%
-0.00
Medicus Pharma Ltd stock is traded at $1.57, with a volume of 183.32K.
It is down -0.64% in the last 24 hours and down -23.90% over the past month.
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.
See More
Previous Close:
$1.57
Open:
$1.6
24h Volume:
183.32K
Relative Volume:
0.58
Market Cap:
$35.11M
Revenue:
-
Net Income/Loss:
$-16.51M
P/E Ratio:
-1.1606
EPS:
-1.3528
Net Cash Flow:
$-15.68M
1W Performance:
+1.96%
1M Performance:
-23.90%
6M Performance:
-54.12%
1Y Performance:
-47.83%
1-Day Range:
$1.52
$1.6188
1-Week Range:
$1.52
$1.70
52-Week Range:
$1.45
$8.94
Medicus Pharma Ltd Stock (MDCX) Company Profile
Name
Medicus Pharma Ltd
Sector
Industry
Phone
610-540-7515
Address
300 CONSHOHOCKEN STATE RD., W. CONSHOHOCKEN
Compare MDCX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MDCX
Medicus Pharma Ltd
|
1.57 | 35.11M | 0 | -16.51M | -15.68M | -1.3528 |
|
LLY
Lilly Eli Co
|
1,108.08 | 952.34B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
207.48 | 493.40B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
233.50 | 395.77B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
NVS
Novartis Ag Adr
|
141.96 | 272.99B | 54.45B | 14.42B | 17.15B | 7.333 |
|
MRK
Merck Co Inc
|
108.60 | 270.22B | 63.90B | 19.05B | 13.05B | 7.5596 |
Medicus Pharma Ltd Stock (MDCX) Latest News
Will Medicus Pharma Ltd. stock deliver better than expected guidanceGeopolitical Risk Analysis & Turn Data into Profits With Our Strategies - ulpravda.ru
Medicus Pharma Ltd. Announces Engagement With Reliant AI to Develop Artificial Intelligence (AI) Driven Clinical Data Analytics Platform - Shelby Star
2026 world cup world class players analysis: Will Medicus Pharma Ltd. Equity Warrant stock benefit from green energy trends2026 world cup usa national team quarterfinals key players low block defense expert forecast expert opinion - ulpravda.ru
Medicus Pharma Ltd. to Present at The Maxim Growth Summit 2025FDL Reporter | The Reporter - fdlreporter.com
Medicus Pharma to present phase 2 data at Biotech Showcase 2026 - Investing.com Nigeria
2026 world cup analysis guide: Why Medicus Pharma Ltd. stock could benefit from AI revolution2026 world cup usa national team group stage top scorers transition play tactical prediction guide - ulpravda.ru
Medicus Pharma enters non-binding LOI with Reliant AI - MSN
Medicus Pharma ramps up partnering push as Phase 2 SkinJect data nears - MSN
Medicus Pharma to highlight multiple Phase 2 catalysts at Biotech Showcase 2026 - Proactive financial news
Medicus Pharma Ramps Up Partnering Push as Phase 2 SkinJect Data Nears - TipRanks
Medicus Pharma Ltd. to Present at Biotech Showcase 2026 as SkinJect Phase 2 Clinical Data Approaches Readout and Partnering Readiness Accelerates - The Manila Times
Medicus Pharma Ltd. to Present at Biotech Showcase 2026 as - GlobeNewswire
Setup Watch: Can Medicus Pharma Ltd stock double in next 5 yearsWeekly Earnings Recap & Reliable Momentum Entry Alerts - moha.gov.vn
Medicus Pharma Ltd. Provides Corporate Updates and Reports Third Quarter 2025 Financial Highlights - Victorville Daily Press
Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement - Pekin Daily Times
Medicus Pharma Ltd. Announces Collaboration with the Gorlin Syndrome Alliance to Pursue Compassionate Use Pathway for Skinject(TM) in Patients with Gorlin Syndrome - The Coloradoan
Dated alerts on Medicus Pharma withdrawn - marketscreener.com
What drives Medicus Pharma Ltd stock priceResistance Breakout Alerts & Test Our Stock Screener — Free Forever - earlytimes.in
Medicus Pharma enters equity distribution agreement for up to $15.3 million By Investing.com - Investing.com Australia
Medicus Pharma enters equity distribution agreement for up to $15.3 million - Investing.com Nigeria
Medicus Pharma Launches At-the-Market Equity Offering Program - TipRanks
Medicus Pharma Signs Equity Distribution Agreement With Maxim Group and Yorkville Securities - TradingView — Track All Markets
Medicus Pharma to offer securities worth up to $100 millionSEC filing - marketscreener.com
Medicus Pharma launches at-the-market equity offering program - MSN
Medicus Pharma Ltd. Announces First Patient Treated in United Arab Emirates (UAE) Sknjct-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin - Lubbock Avalanche-Journal
Can Medicus Pharma Ltd stock double in next 5 yearsPortfolio Gains Summary & Low Risk High Win Rate Stock Picks - moha.gov.vn
Medicus Pharma teams with Reliant AI for study push – ICYMI - Proactive financial news
Medicus Pharma’s warrant inducement agreement announced - MSN
Medicus Pharma taps Reliant AI for data-driven Teverelix clinical development - MSN
Medicus Pharma appoints new CFO - MSN
Reliant AI Partners with Medicus Pharma to Apply Generative AI in Prostate Cancer Clinical Trials - TipRanks
Medicus Pharma Ltd. Receives Full United Kingdom Regulatory and Ethical Approvals To Expand Phase 2 Clinical Study (SKNJCT-003) To Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin - Hillsdale Daily News
Medicus Pharma Ltd. To Present at Brookline Capital Markets - Great Falls Tribune
Medicus Pharma (MDCXW) Stock Analysis Report | Financials & Insights - Benzinga
Will Medicus Pharma Ltd. Equity Warrant stock benefit from green energy trendsBullish Engulfing Patterns & Rapid Portfolio Appreciation - bollywoodhelpline.com
Medicus Pharma partners With Reliant AI to advance AI-driven clinical trial analytics - Proactive financial news
Medicus Fills Phase 2 Trial, Eyes FDA Talks for Needle-Free Skin Cancer - MyChesCo
Reliant AI Engaged by Medicus Pharma to Build AI-Driven Clinical Trial Analytics Platform - TipRanks
Medicus Pharma Ltd Stock (MDCX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.31%
0.67%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):